Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 33 min 8 sec ago

CryoLife Appoints Pat Mackin as President and Chief Executive Officer

Thu, 07/10/2014 - 15:13
ATLANTA, July 10, 2014 -- (Healthcare Sales & Marketing Network) -- CryoLife, Inc. (CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has appointed James Patri...
Devices, Surgery, Personnel
CryoLife, BioGlue, Surgical Adhesive, CryoValve

Smith and Nephew enters commercial agreement to bring robotic navigation to the JOURNEY UNI Knee procedure

Thu, 07/10/2014 - 15:09
LONDON, July 10, 2014 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announced a new commercial agreement with Blue Belt Technologies (BBT), makers of the Navio® Orthopae...
Devices, Orthopaedic
Smith & Nephew, Blue Belt Technologies, JOURNEY UNI, partial knee

Vertex Announces Retirement of Peter Mueller, Ph.D.

Thu, 07/10/2014 - 15:04
BOSTON--(Healthcare Sales & Marketing Network)--Vertex Pharmaceuticals Incorporated (VRTX) today announced that Peter Mueller, Ph.D., Executive Vice President of Global Research and Development and Chief Scientific Officer, will retire after more than 10 y...
Biopharmaceuticals, Personnel
Vertex Pharmaceuticals

Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer

Thu, 07/10/2014 - 14:47
Strong Leadership Team in Place to Advance Novel Immunotherapy Programs CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies, today announ...
Biopharmaceuticals, Oncology, Personnel
Jounce Therapeutics, immunotherapy

CIMTEC announces spin-off company Focal Healthcare, Inc. to develop the new "gold standard" of targeted prostate biopsy and therapy devices for the management of prostate cancer

Wed, 07/09/2014 - 15:01
LONDON, ON , July 9, 2014 (Healthcare Sales & Marketing Network) - Focal Healthcare (Focal) was founded as a spin-off company out of the Centre for Imaging Technology Commercialization (CIMTEC). Focal is developing and marketing MRI-Ultrasound Fusion Biop...
Devices, Oncology, Urology
Focal Healthcare, CIMTEC, imaging, Fusion Biopsy, prostate cancer

Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors

Wed, 07/09/2014 - 14:55
REDWOOD CITY, Calif. , July 9, 2014 (Healthcare Sales & Marketing Network) -- Coherus BioSciences, Inc. ("Coherus"), announced today the appointment of V. Bryan Lawlis, Jr. , Ph.D., former President and CEO of Itero Biopharmaceuticals, to its Bo...
Biopharmaceuticals, Personnel
Coherus Biosciences, biosimilar

RestorGenex Announces Management Changes

Wed, 07/09/2014 - 14:52
CHICAGO--(Healthcare Sales & Marketing Network)--RestorGenex Corporation (RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, announced today several management changes. ...
Biopharmaceuticals, Dermatology, Ophthalmology, Personnel

Paradigm Spine, LLC Announces the Release of Two Independent Prospective Clinical Studies that Substantiate coflex(R) Interlaminar Stabilization After Decompression for the Treatment of Spinal Stenosis

Tue, 07/08/2014 - 13:07
NEW YORK, July 8, 2014 -- (Healthcare Sales & Marketing Network) -- Paradigm Spine, LLC, a leading provider of innovative motion preserving spinal publication of two separate independent prospective clinical research studies that address clinical effectiv...
Devices, Neurosurgery, Orthopaedic
Paradigm Spine, coflex, interlaminar stabilization, Spinal Stenosis

Advances in Trigeminal Nerve Stimulation Featured at European Congress on Epileptology in Stockholm, Sweden

Tue, 07/08/2014 - 13:01
European Clinical Data and Mechanism of Action Results Presented LOS ANGELES, July 8, 2014 -- (Healthcare Sales & Marketing Network) -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-inva...
Devices, Neurology
NeuroSigma, Monarch eTNS, trigeminal nerve stimulation, epilepsy

Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer

Mon, 07/07/2014 - 21:24
Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer Nexavar significantly extended progression-free survival in patients with RAI-refractory differentiated thyroid cancer compared to placebo in the Phase...
Biopharmaceuticals, Oncology, Regulatory
Bayer, Nexavar, thyroid carcinoma

Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer

Mon, 07/07/2014 - 12:04
New York, NY, July 7, 2014 -- (Healthcare Sales & Marketing Network) -- Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women, toda...
Diagnostics, Personnel
Provista Diagnostics

JenaValve Names David J. Drachman Chief Executive Officer

Mon, 07/07/2014 - 11:58
Cardiovascular Medical Device Industry Veteran to Lead JenaValve in Broader Commercialization of TAVI Systems for Treatment of Aortic Valve Disease IRVINE, Calif. & MUNICH--(Healthcare Sales & Marketing Network)--JenaValve Technology, Inc., a privately-...
Devices, Cardiology, Personnel
JenaValve Technology, TAVI, JenaValve, JenaClip

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong